Rapid Communication Open Access
Copyright ©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Aug 14, 2006; 12(30): 4873-4874
Published online Aug 14, 2006. doi: 10.3748/wjg.v12.i30.4873
Comparing mass screening techniques for gastric cancer in Japan
Atsushi Tashiro, Yutaka Takeuchi, Niigata Public Health and Sanitation Center, Niigata 951-8550, Japan
Atsushi Tashiro, Masatoshi Sano, Koichi Kinameri, Kazutaka Fujita, Yutaka Takeuchi, Committee of Gastric Cancer Screening, Niigata City Medical Association, Niigata 951-8131, Japan
Author contributions: All authors contributed equally to the work.
Correspondence to: Atsushi Tashiro, MD, Niigata Public Health and Sanitation Center, 1-602-1 Gakkocho-dori Niigata 951-8550, Japan. tashi@mail.lamen.or.jp
Telephone: +81-25-2281000 Fax: +81-25-2289688
Received: April 10, 2006
Revised: May 1, 2006
Accepted: May 25, 2006
Published online: August 14, 2006

Abstract

AIM: To discuss the efficacy of endoscopic mass screening for gastric cancer.

METHODS: The data used in this study were the results of mass screening programs for gastric cancer in Niigata City from 2002 to 2004. The number of participants was 35 089 in 2002, 34 557 in 2003 and 36 600 in 2004. The finding ratio referred to the final diagnosis of gastric cancer after a double check of endoscopic files and histological findings. The costs of identifying one case of gastric cancer were calculated based on the total expense for each screening program and additional close examinations.

RESULTS: From the analysis of individual screening program with endoscopy, individual screening program with X-ray (ISX) and mass screening program with photofluorography (MSP) in reference to the finding ratio of gastric cancer, endoscopic examination was the best for detecting early gastric cancer, the finding ratio was 0.87% in 2004, approximately 2.7 and 4.6 times higher than those of the ISX and MSP groups. In addition, this novel method was the cheapest means regarding the cost of identifying one case of gastric cancer, which was estimated to be 1 608 000 Japanese yen in 2004.

CONCLUSION: Endoscopic mass screening is a promising method and can be effectively applied if a sufficient number of skilled endoscopists become available to staff the system and if city offices support it.

Key Words: Mass screening, Gastric cancer, Endoscopy, Cost effectiveness



INTRODUCTION

Gastric cancer is recognized worldwide as the second leading cause of cancer mortality[1]. In Japan, non-cardia gastric cancer still remains the major cause of cancer death, although recently the mortality rate has begun to decrease [2]. With reference to this change, it has been reported that early detection of gastric cancer may contribute to decreases in the mortality rate[3,4].

Japan has carried out ongoing programs to prevent gastric cancer death by mass X-ray screening methods to detect gastric cancer in its early stages[4,5]. In recent years, endoscopy has been applied instead of X-ray as the initial mass screening method in several cities in Japan, and endoscopic mass screening has been utilized in Niigata City since 2003. The efficacy of endoscopic mass screening is discussed herein.

It is known that the finding ratio of early gastric cancer with endoscopy is higher than that with X-ray[6], making endoscopy a highly effective screening method[7]. There are, however, cost problems related to applying endoscopic mass screening[6,7]. Endoscopic screening is more expensive than direct X-ray screening (ordinary upper GI) in the Japanese medical system. Although the balance is approximately 3400 Japanese yen, because of financial problems in city offices, at the start of the present study, the costs for the two screening procedures were decided to be the same for a while.

MATERIALS AND METHODS
Subjects

The data used in this study were the results of mass screening programs for gastric cancer in Niigata City from 2002 to 2004. The number of participants was 35 089 in 2002, 34 557 in 2003 and 36 600 in 2004. As employees have their own mass screening system of Japan, nonemployees participated in these mass screenings. All screening participants aged 40 or over could choose one of the three programs utilizing endoscopy (ISE), direct X-ray (ISX) and photofluorography (MSP: indirect X-ray with a small sized film) each.

Analysis

The finding ratio referred to the final diagnosis of gastric cancer after a double check of endoscopic files and histological findings. The costs of identifying one case of gastric cancer with each method were calculated based on the total expense for each screening program and additional close examinations.

Every citizen participates in some type of a medical insurance program, which enables all Japanese have access to medical services for next close examinations at the same costs. X-ray examination of suspected gastric cancer in ISX and MSP groups showed that the patients with suspected lesion could be referred to the endoscopists to receive endoscopy with biopsy for getting a final histogical diagnosis. We included these close examination fees in addition to the screening fee for cost analysis. In ISE group the costs of endoscopic screening and additional biopsy at the same time (if needed) were also counted.

RESULTS
Finding ratio

In 2004, the finding ratio in the ISE group was 0.87%, approximately 2.7 and 4.6 times higher than those of the ISX and MSP groups respectively and the rate of early gastric cancer in the ISE group was the highest among the three groups.

Cost analysis

The cost of identifying one case of gastric cancer was estimated to be 1 608 000 Japanese yen in ISE, 4 177 000 Japanese yen in ISX, and 3 290 000 Japanese yen in MSP in 2004. In the same condition of ordinary medical fee for endoscopic examination, the cost of ISE increased to 1 998 000 Japanese yen.

These results indicated that endoscopic mass screening was the best and cheapest means for detecting and identifying gastric cancer. The results of each mass screening are shown in Table 1.

Table 1 Transition before and after adoption of endoscopic screening program.
200220032004
Participants (n)ISE-811811 679
ISX28 33220 05819 011
MSP675763815910
Detection rate (%)ISE-0.810.87
ISX0.330.310.32
MSP0.250.220.19
Rate of early gastric cancer (%)ISE-74.275.5
ISX40.856.563.9
MSP46.771.454.5
Cost ( J YEN )ISE-1 693 0001 608 000
ISE22 113 0001 998 000
ISX5 113 0004 365 0004 177 000
MSP2 712 0002 792 0003 290 000
DISCUSSION

To decrease cancer death, early detection and subsequent surveillance are necessary[8]. Although eradication of H pylori infection is the most effective, the incidence of gastric cancer would remain high for several decades to come[9]. Endoscopic mass screening for gastric cancer is effective in identifying cancer in its early stages[6], but endoscopic screening is more expensive than direct X-ray screening in the Japanese medical system. In this study our cost analysis showed that even if we applied ordinary examination fee for endoscopic mass screening, this novel approach was still the most superior method in cost-effectiveness for finding gastric cancer patients.

On the other hand, endoscopic mass screening is practically not appropriative for wide application due to the limited number of skilled endoscopists[6]. In Niigata City, however, we fortunately have enough endoscopists who have the title of authorized specialists as a board-certified member to examine more than 10 000 cases yearly, making it feasible to adopt an endoscopic screening system.

In mass screening systems for gastric cancer, endo-scopic examination is a promising method and can be effectively applied if a sufficient number of skilled endoscopists become available to staff the system and if city offices support it.

ACKNOWLEDGMENTS

The authors thank Dr. Kazuei Ogoshi for his assistance and advice in managing the endoscopic mass screening programs and interpretation of the results.

Footnotes

S- Editor Wang J L- Editor Wang XL E- Editor Ma N

References
1.  Moayyedi P, Ford A. Recent developments in gastroenterology. BMJ. 2002;325:1399-1402.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 11]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
2.  Sun J, Misumi J, Shimaoka A, Aoki K, Esaki F. Stomach cancer-related mortality. Eur J Cancer Prev. 2001;10:61-67.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 22]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
3.  Lambert R, Guilloux A, Oshima A, Pompe-Kirn V, Bray F, Parkin M, Ajiki W, Tsukuma H. Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer. 2002;97:811-818.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 79]  [Cited by in F6Publishing: 92]  [Article Influence: 4.2]  [Reference Citation Analysis (0)]
4.  Kampschöer GH, Fujii A, Masuda Y. Gastric cancer detected by mass survey. Comparison between mass survey and outpatient detection. Scand J Gastroenterol. 1989;24:813-817.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 27]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
5.  Shiratori Y, Nakagawa S, Kikuchi A, Ishii M, Ueno M, Miyashita T, Sakurai T, Negami J, Suzuki T, Sato I. Significance of a gastric mass screening survey. Am J Gastroenterol. 1985;80:831-834.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Takemoto C, Isechi T, Matsumoto J, Kusano K, Mishige K, Nuruki F. Current status and problems of screening for gastric cancer using endoscopy. Nihon Shokaki Shudankenshin Gakkaishi. 2004;42:322-330 (in Japanese).  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Waye JD, Aabakken L, Armengol-Miro JR, Llorens P, Williams CB, Zhang QL. Screening for GI cancer and payment mechanisms. Gastrointest Endosc. 2002;55:453-454.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 9]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
8.  Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JW. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut. 2002;50:378-381.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 183]  [Cited by in F6Publishing: 178]  [Article Influence: 8.1]  [Reference Citation Analysis (0)]
9.  McColl KE. Screening for early gastric cancer. Gut. 2005;54:740-742.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 4]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]